Analystreport

Ovid Therapeutics Inc (NASDAQ: OVID) had its "buy" rating re-affirmed by analysts at Cowen Inc.

Ovid Therapeutics Inc.  (OVID) 
Last ovid therapeutics inc. earnings: 3/11 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.ovidrx.com